Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
MAPK signaling pathway | R-HSA-9652817 | map04010 | 5186324 | None | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | 5186324 | None | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | 5186324 | None | drug-path |
Axon guidance | R-HSA-422475 | map04360 | 5114445 | None | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | 5114445 | None | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | nicotinic acid | 938 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | nicotinic acid | 938 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | nicotinic acid | 938 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | nicotinic acid | 938 | drug-path |
Asthma | R-HSA-444620 | map05310 | nicotinic acid | 938 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | nicotinic acid | 938 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | nicotinic acid | 938 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | nicotinic acid | 938 | drug-path |
Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | nicotinic acid | 938 | drug-path |
Type II diabetes mellitus | R-HSA-2127377 | map04930 | nicotinic acid | 938 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | nicotinic acid | 938 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | nicotinic acid | 938 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | proscillaridin | 5284613 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | proscillaridin | 5284613 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | proscillaridin | 5284613 | drug-path |